• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vet Res . In vitro and in vivo studies of GAPLINC identify it as a critical host factor involved in the regulation of influenza A virus infection

tetano

Editor, Senior Moderator
Vet Res


. 2026 Jul 16;57(1):136.
doi: 10.1186/s13567-026-01783-1.
In vitro and in vivo studies of GAPLINC identify it as a critical host factor involved in the regulation of influenza A virus infection

Lulu Wang[SUP] 1 2 3 [/SUP], Haiyan Xu[SUP] 1 2 3 [/SUP], Jiajie Li[SUP] 1 2 [/SUP], Qianxi Zhang[SUP] 1 2 [/SUP], Guanghui Chui[SUP] 1 2 [/SUP], Shihong Yan[SUP] 1 2 [/SUP], Song Wang[SUP] 1 2 3 [/SUP], Shile Huang[SUP] 4 [/SUP], Ji-Long Chen[SUP] 5 6 7 [/SUP]


Affiliations
Abstract

Although previous studies have suggested a role for GAPLINC in regulating influenza A virus (IAV) infection, the functional involvement of GAPLINC in IAV infection in vitro and in vivo remains largely unknown. Here, we found that expression of lncRNA GAPLINC is significantly downregulated by infections with several strains of IAV, including PR8, WSN, H3N2, and H9N2. Interestingly, infections with several other viruses, such as pseudorabies virus (PRV), Sendai virus (SeV), and Herpes simplex virus (HSV), also result in a significant reduction in GAPLINC expression. During IAV infection, activation of NF-κB and the downstream IL-6/STAT3 signaling pathway contribute, at least in part, to the downregulation of GAPLINC expression. Knockdown of GAPLINC in host cells impairs the viral replication, whereas overexpression of GAPLINC increases the viral titers. Both heterozygous GAPLINC knockout (KO) mice (GAPLINC[SUP]+/-[/SUP]) and homozygous GAPLINC KO mice (GAPLINC[SUP]⁻/⁻[/SUP]) were further employed to determine its function in vivo. GAPLINC knockout renders mice more resistant to IAV infection than wild-type counterparts, as evidenced by lower viral load and lung injury, slower body weight loss, and improved survival. We confirmed that GAPLINC obviously suppresses the IRF3 activation in IAV-infected cells. Moreover, we noticed that inhibition of ATG7-involved autophagy weakens the pro-viral activity of GAPLINC. Together, the results support the conclusion that GAPLINC plays a critical role in enhancing the pathogenesis of IAV, at least by targeting the IRF3 and ATG7-mediated autophagy pathway.

Keywords: ATG7; GAPLINC; Influenza A virus; LncRNA; autophagy.

 
Back
Top